New and Evolving Therapeutic Targets in Lung Cancer: Expert Guidance in Incorporating Biomarker Testing to Deliver Precision Therapy

Download All
Gain expert insights on how to test for new and emerging molecular targets and incorporate targeted agents into the care of your patients with lung cancer with downloadable slides and on-demand Webcasts from live meetings, biomarker summary handouts, and a decision support tool providing the latest individualized guidance on precision therapy for NSCLC.
Leora Horn, MD, MSc, FRCPC
Edward S. Kim, MD, FACP, FASCO
Eric Q. Konnick, MD, MS
Nathan Pennell, MD, PhD
Laura J. Tafe, MD

Downloadable Slidesets

Download these slides to review expert insights from a medical oncologist on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Nathan Pennell, MD, PhD Released: November 12, 2020

Download these slides to review expert insights from a pathologist on best practices for biomarker testing in the treatment of patients with advanced NSCLC.

Laura J. Tafe, MD Released: November 12, 2020

Download this short summary slideset of key takeaway points from a live CCO meeting series on the evolving use of biomarkers for precision therapy in lung cancer.

Eric Q. Konnick, MD, MS Nathan Pennell, MD, PhD Released: May 29, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar focused on the use of new biomarkers critical to lung cancer care today.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP, FASCO Released: June 26, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar featuring a medical oncologist and molecular pathologist discussing established and emerging biomarkers critical to optimal treatment of patients with advanced NSCLC.

Nathan Pennell, MD, PhD Laura J. Tafe, MD Released: November 24, 2020

Download these slides from our live meeting series to gain expert insights on how to integrate new and emerging molecular targets into the care of your patients with lung cancer.

Eric Q. Konnick, MD, MS Nathan Pennell, MD, PhD Released: May 5, 2020

Download this slideset on new and emerging molecular targets critical to lung cancer care, including expert insight on NTRK fusions, RET fusions, and MET exon 14 skipping mutations.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP, FASCO Released: June 25, 2020

Download this slideset for expert insights on the role of biomarkers in the optimal use of immunotherapy in the care of patients with NSCLC.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP, FASCO Released: June 25, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Lilly

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings